Get unlimited access to Bruins cup coverage - Just 99¢

The Boston Globe

Markets

MASS. MOVERS

Vertex slips as executives shift

Vertex Pharmaceuticals Inc. has begun seeking a new head of its commercial team. The company reported Friday that chief commercial officer Nancy Wysenksi is retiring. Vertex last month revealed it had released incorrect clinical data that overstated the benefit of a cystic fibrosis therapy, and led to a 55 percent rise in its stock May 7. On May 29, the shares fell the most in three years after the company revised the data. Chief legal officer Ty Howton is also leaving, to be replaced by Kenneth Horton.

Stay with the story. Get full access to BostonGlobe.com for just 99¢

Unlimited access to BostonGlobe.com for only 99¢ for the first 4 weeks. You can cancel at any time.

  • The FULL story all day: Enjoy all of the high-quality, in-depth journalism in the print edition of the Boston Globe — plus breaking news that's updated 24/7.
  • A truly reader-friendly format: It's online news that looks and reads just like the newspaper — uncluttered, uninterrupted.
  • Breakthrough technology: The responsive design automatically adapts content so it always reads perfectly on the digital device of your choice.
Get started today

BostonGlobe.comSubscriber Log In

Contact us for help

  • Phone

    888-MY-GLOBE

    Monday-Friday 6:00 a.m.- 5:00 p.m.

    Saturday, Sunday and Holidays 7:30 a.m.- 12:00 noon

  • Chat

    Start a chat

    Monday-Sunday 8:00 a.m.- 5:00 p.m.

  • E-mail

    support@bostonglobe.com